dc.contributor.author | Asa, S. | |
dc.contributor.author | Sonmezoglu, K. | |
dc.contributor.author | Halac, M. | |
dc.contributor.author | Tan, Y. Z. | |
dc.contributor.author | Ozhan, M. | |
dc.contributor.author | Yilmaz, S. | |
dc.date.accessioned | 2021-03-06T21:13:55Z | |
dc.date.available | 2021-03-06T21:13:55Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Yilmaz S., Tan Y. Z. , Ozhan M., Halac M., Asa S., Sonmezoglu K., "FDG PET/CT in monitoring treatment of retroperitoneal fibrosis", REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.31, ss.338-339, 2012 | |
dc.identifier.issn | 2253-654X | |
dc.identifier.other | av_fdc2d2e5-abc1-4450-be69-068f2970c6bd | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/165996 | |
dc.identifier.uri | https://doi.org/10.1016/j.remn.2012.04.001 | |
dc.description.abstract | Retroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved. | |
dc.language.iso | eng | |
dc.subject | Nükleer Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.title | FDG PET/CT in monitoring treatment of retroperitoneal fibrosis | |
dc.type | Makale | |
dc.relation.journal | REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 31 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 338 | |
dc.identifier.endpage | 339 | |
dc.contributor.firstauthorID | 206780 | |